Coexpression cluster:C642: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:27, 17 September 2013
Full id: C642_Whole_blood_optic_substantia_globus_corpus_thalamus
Phase1 CAGE Peaks
Hg19::chr10:111985777..111985788,+ | p4@MXI1 |
Hg19::chr10:22825620..22825656,- | p2@PIP4K2A |
Hg19::chr10:22825878..22825894,- | p5@PIP4K2A |
Hg19::chr10:22830771..22830779,- | p@chr10:22830771..22830779 - |
Hg19::chr10:23002092..23002110,- | p@chr10:23002092..23002110 - |
Hg19::chr10:23003155..23003214,+ | p@chr10:23003155..23003214 + |
Hg19::chr10:23003406..23003417,- | p4@PIP4K2A |
Hg19::chr10:23003436..23003459,- | p3@PIP4K2A |
Hg19::chr10:23003460..23003562,- | p1@PIP4K2A |
Hg19::chr12:21680866..21680902,+ | p6@C12orf39 |
Hg19::chr14:105147464..105147523,+ | p1@ENST00000540171 |
Hg19::chr4:90758153..90758176,- | p5@SNCA |
Hg19::chr8:27468262..27468277,- | p27@CLU |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006629 | lipid metabolic process | 0.0108070060423257 |
GO:0006916 | anti-apoptosis | 0.0108070060423257 |
GO:0016235 | aggresome | 0.0108070060423257 |
GO:0048523 | negative regulation of cellular process | 0.0108070060423257 |
GO:0006644 | phospholipid metabolic process | 0.0108070060423257 |
GO:0048519 | negative regulation of biological process | 0.0108070060423257 |
GO:0043066 | negative regulation of apoptosis | 0.0108070060423257 |
GO:0001956 | positive regulation of neurotransmitter secretion | 0.0108070060423257 |
GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity | 0.0108070060423257 |
GO:0043069 | negative regulation of programmed cell death | 0.0108070060423257 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 0.0116053713801532 |
GO:0042416 | dopamine biosynthetic process | 0.0116053713801532 |
GO:0006643 | membrane lipid metabolic process | 0.0116053713801532 |
GO:0016234 | inclusion body | 0.0141251242095994 |
GO:0031018 | endocrine pancreas development | 0.0141251242095994 |
GO:0001963 | synaptic transmission, dopaminergic | 0.0154484450428978 |
GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 0.0155330633749191 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 0.0155330633749191 |
GO:0048168 | regulation of neuronal synaptic plasticity | 0.0155330633749191 |
GO:0031016 | pancreas development | 0.0155330633749191 |
GO:0051220 | cytoplasmic sequestering of protein | 0.0155330633749191 |
GO:0042423 | catecholamine biosynthetic process | 0.0155330633749191 |
GO:0042308 | negative regulation of protein import into nucleus | 0.0155330633749191 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 0.0155330633749191 |
GO:0042417 | dopamine metabolic process | 0.0155330633749191 |
GO:0046928 | regulation of neurotransmitter secretion | 0.0156890392781357 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 0.0156890392781357 |
GO:0042127 | regulation of cell proliferation | 0.0158233579816069 |
GO:0051224 | negative regulation of protein transport | 0.0158233579816069 |
GO:0048167 | regulation of synaptic plasticity | 0.0182152392557906 |
GO:0042136 | neurotransmitter biosynthetic process | 0.0182152392557906 |
GO:0050803 | regulation of synapse structure and activity | 0.0184797701797707 |
GO:0048489 | synaptic vesicle transport | 0.0184797701797707 |
GO:0042981 | regulation of apoptosis | 0.0184797701797707 |
GO:0043067 | regulation of programmed cell death | 0.0184797701797707 |
GO:0007270 | nerve-nerve synaptic transmission | 0.0184797701797707 |
GO:0042221 | response to chemical stimulus | 0.0184797701797707 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.0184797701797707 |
GO:0042991 | transcription factor import into nucleus | 0.0184797701797707 |
GO:0042306 | regulation of protein import into nucleus | 0.0184797701797707 |
GO:0033157 | regulation of intracellular protein transport | 0.0184797701797707 |
GO:0016307 | phosphatidylinositol phosphate kinase activity | 0.0184797701797707 |
GO:0032507 | maintenance of cellular protein localization | 0.0191052624903955 |
GO:0051651 | maintenance of cellular localization | 0.0191052624903955 |
GO:0046488 | phosphatidylinositol metabolic process | 0.0191052624903955 |
GO:0032386 | regulation of intracellular transport | 0.0191052624903955 |
GO:0045185 | maintenance of protein localization | 0.0191052624903955 |
GO:0006584 | catecholamine metabolic process | 0.0191052624903955 |
GO:0018958 | phenol metabolic process | 0.0192959568263883 |
GO:0051223 | regulation of protein transport | 0.0192959568263883 |
GO:0006958 | complement activation, classical pathway | 0.0192959568263883 |
GO:0007399 | nervous system development | 0.0192959568263883 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0192959568263883 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 0.0195905268674936 |
GO:0051051 | negative regulation of transport | 0.0196979209913166 |
GO:0008283 | cell proliferation | 0.0196979209913166 |
GO:0042133 | neurotransmitter metabolic process | 0.0197944119925687 |
GO:0035270 | endocrine system development | 0.0198421677209551 |
GO:0044255 | cellular lipid metabolic process | 0.0198421677209551 |
GO:0042401 | biogenic amine biosynthetic process | 0.0199776320823133 |
GO:0019717 | synaptosome | 0.0208035701289321 |
GO:0001727 | lipid kinase activity | 0.0214492439905879 |
GO:0006956 | complement activation | 0.0214492439905879 |
GO:0002541 | activation of plasma proteins during acute inflammatory response | 0.0214492439905879 |
GO:0007269 | neurotransmitter secretion | 0.0214492439905879 |
GO:0006915 | apoptosis | 0.0214492439905879 |
GO:0051235 | maintenance of localization | 0.0214492439905879 |
GO:0012501 | programmed cell death | 0.0214492439905879 |
GO:0042398 | amino acid derivative biosynthetic process | 0.0214492439905879 |
GO:0008219 | cell death | 0.0228610036321127 |
GO:0016265 | death | 0.0228610036321127 |
GO:0045597 | positive regulation of cell differentiation | 0.0229958414124646 |
GO:0016064 | immunoglobulin mediated immune response | 0.0245579892626077 |
GO:0019724 | B cell mediated immunity | 0.0245579892626077 |
GO:0016043 | cellular component organization and biogenesis | 0.0245579892626077 |
GO:0045055 | regulated secretory pathway | 0.0245579892626077 |
GO:0051046 | regulation of secretion | 0.0269735680637904 |
GO:0042493 | response to drug | 0.0284263292519867 |
GO:0048471 | perinuclear region of cytoplasm | 0.0285103237305022 |
GO:0004428 | inositol or phosphatidylinositol kinase activity | 0.0289770518895741 |
GO:0051649 | establishment of cellular localization | 0.0289770518895741 |
GO:0051094 | positive regulation of developmental process | 0.0290514758545434 |
GO:0003001 | generation of a signal involved in cell-cell signaling | 0.0290514758545434 |
GO:0051641 | cellular localization | 0.0290514758545434 |
GO:0002253 | activation of immune response | 0.0290514758545434 |
GO:0002449 | lymphocyte mediated immunity | 0.0290514758545434 |
GO:0040012 | regulation of locomotion | 0.0290514758545434 |
GO:0040011 | locomotion | 0.0290514758545434 |
GO:0006576 | biogenic amine metabolic process | 0.0290514758545434 |
GO:0006959 | humoral immune response | 0.0290514758545434 |
GO:0002250 | adaptive immune response | 0.0290514758545434 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0290514758545434 |
GO:0002443 | leukocyte mediated immunity | 0.029178169694758 |
GO:0001505 | regulation of neurotransmitter levels | 0.029178169694758 |
GO:0002526 | acute inflammatory response | 0.0292394509575832 |
GO:0030384 | phosphoinositide metabolic process | 0.0292994125000015 |
GO:0048468 | cell development | 0.0304863311065692 |
GO:0050778 | positive regulation of immune response | 0.0304863311065692 |
GO:0002684 | positive regulation of immune system process | 0.0305316306197012 |
GO:0006575 | amino acid derivative metabolic process | 0.0316247408588697 |
GO:0006606 | protein import into nucleus | 0.0333872700655214 |
GO:0050776 | regulation of immune response | 0.033417100397404 |
GO:0051170 | nuclear import | 0.033417100397404 |
GO:0002682 | regulation of immune system process | 0.0337672299085275 |
GO:0006650 | glycerophospholipid metabolic process | 0.0337781048632552 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0347763791412003 |
GO:0003714 | transcription corepressor activity | 0.0351034490641594 |
GO:0002252 | immune effector process | 0.0354192425605005 |
GO:0051049 | regulation of transport | 0.0354192425605005 |
GO:0045087 | innate immune response | 0.0363649480858612 |
GO:0009309 | amine biosynthetic process | 0.0369227283928866 |
GO:0048667 | neuron morphogenesis during differentiation | 0.0369227283928866 |
GO:0006979 | response to oxidative stress | 0.0369227283928866 |
GO:0048812 | neurite morphogenesis | 0.0369227283928866 |
GO:0017038 | protein import | 0.0372073074498277 |
GO:0000904 | cellular morphogenesis during differentiation | 0.0380869794858592 |
GO:0031175 | neurite development | 0.0404372637687916 |
GO:0048731 | system development | 0.0412386355147545 |
GO:0045595 | regulation of cell differentiation | 0.0423856905548066 |
GO:0044271 | nitrogen compound biosynthetic process | 0.0429005750847962 |
GO:0048666 | neuron development | 0.0441884666926329 |
GO:0006913 | nucleocytoplasmic transport | 0.0441884666926329 |
GO:0051169 | nuclear transport | 0.0443931938023867 |
GO:0048869 | cellular developmental process | 0.0489034391672832 |
GO:0030154 | cell differentiation | 0.0489034391672832 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 1.42e-15 | 168 |
angioblastic mesenchymal cell | 1.42e-15 | 168 |
hematopoietic oligopotent progenitor cell | 2.57e-15 | 161 |
hematopoietic multipotent progenitor cell | 2.57e-15 | 161 |
hematopoietic cell | 2.65e-13 | 177 |
leukocyte | 8.21e-13 | 136 |
myeloid cell | 8.88e-11 | 108 |
common myeloid progenitor | 8.88e-11 | 108 |
hematopoietic lineage restricted progenitor cell | 1.16e-10 | 120 |
nongranular leukocyte | 2.46e-10 | 115 |
myeloid leukocyte | 7.47e-08 | 72 |
myeloid lineage restricted progenitor cell | 7.65e-07 | 66 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 3.61585 |
MA0004.1 | 0.297884 |
MA0006.1 | 1.55315 |
MA0007.1 | 0.282081 |
MA0009.1 | 0.724811 |
MA0014.1 | 3.58868 |
MA0017.1 | 0.57848 |
MA0019.1 | 1.09485 |
MA0024.1 | 0.6245 |
MA0025.1 | 0.854131 |
MA0027.1 | 2.32165 |
MA0028.1 | 0.181601 |
MA0029.1 | 0.642879 |
MA0030.1 | 0.63197 |
MA0031.1 | 1.39986 |
MA0038.1 | 1.00626 |
MA0040.1 | 0.648455 |
MA0041.1 | 0.313738 |
MA0042.1 | 0.286538 |
MA0043.1 | 0.725115 |
MA0046.1 | 0.714324 |
MA0048.1 | 1.28679 |
MA0050.1 | 2.18586 |
MA0051.1 | 0.997995 |
MA0052.1 | 0.652145 |
MA0055.1 | 2.63233 |
MA0056.1 | 0 |
MA0057.1 | 0.294933 |
MA0058.1 | 0.219229 |
MA0059.1 | 0.218203 |
MA0060.1 | 0.0892161 |
MA0061.1 | 0.255087 |
MA0063.1 | 0 |
MA0066.1 | 0.387854 |
MA0067.1 | 1.03434 |
MA0068.1 | 0.196125 |
MA0069.1 | 0.710614 |
MA0070.1 | 0.69985 |
MA0071.1 | 0.35315 |
MA0072.1 | 0.695528 |
MA0073.1 | 2.119 |
MA0074.1 | 1.76626 |
MA0076.1 | 0.231962 |
MA0077.1 | 0.688123 |
MA0078.1 | 0.473657 |
MA0081.1 | 0.218332 |
MA0083.1 | 0.732051 |
MA0084.1 | 1.21913 |
MA0087.1 | 0.693179 |
MA0088.1 | 0.170244 |
MA0089.1 | 0 |
MA0090.1 | 0.243681 |
MA0091.1 | 0.30011 |
MA0092.1 | 0.268302 |
MA0093.1 | 0.171791 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.399896 |
MA0101.1 | 0.17426 |
MA0103.1 | 0.162663 |
MA0105.1 | 0.26318 |
MA0106.1 | 0.424592 |
MA0107.1 | 0.385539 |
MA0108.2 | 0.568002 |
MA0109.1 | 0 |
MA0111.1 | 0.254772 |
MA0113.1 | 0.439505 |
MA0114.1 | 0.376635 |
MA0115.1 | 0.959312 |
MA0116.1 | 0.391626 |
MA0117.1 | 0.76111 |
MA0119.1 | 0.205526 |
MA0122.1 | 0.786181 |
MA0124.1 | 0.918678 |
MA0125.1 | 0.83671 |
MA0130.1 | 0 |
MA0131.1 | 0.490408 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 2.9791 |
MA0136.1 | 0.393782 |
MA0139.1 | 0.870578 |
MA0140.1 | 0.350813 |
MA0141.1 | 0.216821 |
MA0142.1 | 0.541045 |
MA0143.1 | 0.439666 |
MA0144.1 | 0.35188 |
MA0145.1 | 1.29615 |
MA0146.1 | 0.191696 |
MA0147.1 | 0.793354 |
MA0148.1 | 0.855011 |
MA0149.1 | 0.342334 |
MA0062.2 | 1.35421 |
MA0035.2 | 0.350194 |
MA0039.2 | 0.809044 |
MA0138.2 | 0.474787 |
MA0002.2 | 0.0821804 |
MA0137.2 | 0.186529 |
MA0104.2 | 0.620335 |
MA0047.2 | 0.413608 |
MA0112.2 | 0.0689988 |
MA0065.2 | 0.0781722 |
MA0150.1 | 0.238884 |
MA0151.1 | 0 |
MA0152.1 | 0.356591 |
MA0153.1 | 0.820317 |
MA0154.1 | 0.257061 |
MA0155.1 | 0.560882 |
MA0156.1 | 0.18827 |
MA0157.1 | 0.515488 |
MA0158.1 | 0 |
MA0159.1 | 0.398903 |
MA0160.1 | 0.332385 |
MA0161.1 | 0 |
MA0162.1 | 1.67029 |
MA0163.1 | 0.390307 |
MA0164.1 | 0.450848 |
MA0080.2 | 0.511865 |
MA0018.2 | 0.425847 |
MA0099.2 | 0.356906 |
MA0079.2 | 3.42699 |
MA0102.2 | 1.25596 |
MA0258.1 | 0.335505 |
MA0259.1 | 0.132107 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
SRF#6722 | 4 | 4.24528561912856 | 0.0115903477001898 | 0.042349799652245 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.